Due to the fact that VEGF-B shows only minor angiogenic activity, VEGF-B has been shown to have better safety profile as a neuroprotective survival molecule than VEGF-A, [90] and might therefore be a good therapeutic target for neurodegenerative diseases. The gene discussed is VEGFA; the disease is neurodegenerative disease.